Studies with human cancer showed that downregulation of miR-21 increased PTEN expression, inhibited PI3K/AKT activity, promoted apoptosis, and reduced proliferation (Meng et al., 2007; Liu et al., 2019). The gene discussed is AKT1; the disease is cancer.